24/7 Market News Snapshot 07 July, 2025 – Artelo Biosciences, Inc. Common Stock (NASDAQ:ARTL)

July 7, 2025

DENVER, Colo., 07 July, 2025 (www.247marketnews.com) – (NASDAQ:ARTL) are discussed in this article.
Artelo Biosciences, Inc. (NASDAQ:ARTL) has garnered significant attention recently due to remarkable trading activity and the presentation of promising preclinical data on its groundbreaking drug candidate, ART12.11. The stock opened at $21.56 but has seen a staggering transformation, currently trading around $14.51, reflecting an extraordinary change of 44.37% from the previous session’s close of $10.05, on a robust trading volume of 6.72 million shares. This fluctuation indicates heightened investor interest and positions ARTL as a noteworthy entity in the biotech sector, with potential for further bullish momentum.

At the recent 35th Annual International Cannabinoid Research Society Symposium, Artelo showcased compelling data demonstrating the antidepressant-like activity and cognitive benefits of ART12.11, a proprietary cocrystal drug. Researcher Matt Jones presented findings detailing ART12.11’s ability to alleviate stress-induced depressive symptoms, showcasing efficacy comparable to sertraline (Zoloft), a well-established selective serotonin reuptake inhibitor (SSRI). The poster presentation illustrated that a 28-day treatment with ART12.11 significantly improved behavioral function in animal models, restoring the ability to experience pleasure and enhancing social motivation.

Gregory D. Gorgas, the President and Chief Executive Officer of Artelo Biosciences, underscored the implications of these findings, noting that ART12.11 not only demonstrates potent antidepressant effects but also holds promise for cognitive restoration, a crucial area often overlooked by current therapies. As Artelo Biosciences continues its commitment to addressing critical unmet medical needs with innovative therapeutic solutions, the advancements surrounding ART12.11 represent a significant step in redefining treatment strategies for patients battling depression and anxiety disorders.

Related news for (ARTL)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.